Il polmone nella sindrome da anticorpi antifosfolipidi

Translated title of the contribution: The lung in the antiphospholipid syndrome

Research output: Contribution to journalArticlepeer-review


Patients with antiphospholipid syndrome, either primary or associated with other connective tissue diseases, may develop a broad spectrum of pulmonary diseases. The most common complications are pulmonary thromboembolism and pulmonary hypertension; other complications such as microvascular pulmonary thrombosis, alveolar hemorrage, acute respiratory distress syndrome, fibrosing alveolitis has been also reported. The therapeutic approach in these patients do not differ from other complications of antiphospholipid syndrome, with the mandatory use of oral anticoagulant. In the case of pulmonary hypertension secondary to thromboembolism a conservative surgical approach using thromboendarterectomy may be useful.

Translated title of the contributionThe lung in the antiphospholipid syndrome
Original languageItalian
Pages (from-to)397-404
Number of pages8
JournalProgressi in Reumatologia
Issue number4
Publication statusPublished - 2003

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'The lung in the antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this